This week’s UK tech funding deals include neurodegenerative treatment developer NRG Therapeutics, AI email assistant Fyxer and more.
UKTN tracked £103.2m worth of UK tech investment this week (8 September to 12 September), an 80% week-on-week decrease across five funding rounds.
Here’s your weekly roundup of UK tech startup funding deals.
NRG Therapeutics – £50m
Sector: Health tech
HQ: Stevenage
Round: Series B
Investors: SV Health Investors, M Ventures, Novartis Venture Fund, Criteria Bio Ventures, Omega Funds, Brandon Capital and British Business Bank
Founded in 2018, NRG Therapeutics is developing novel treatments for severe neurodegenerative conditions.
Read more
Fyxer AI – £22m
Sector: AI
HQ: London
Round: Series B
Investors: Madrona, Lakestar Capital, 20VC, 20Growth and angels
Founded in 2023, Fyxer AI is an AI-powered email and meeting assistant….
